Restoration of BRAK / CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinomaShigeyuki Ozawa, Ryu‐Ichiro Hata|Cancer Science|2009Cited by 44